Skip to main content
FishtownFish wrapped around the rod of AsclepiusMedicine
Philadelphia Primary Care
Articles
Digital Health Literacy
Cut through health misinformation
Symptoms
What your body is telling you
Treatments
Protocols, prescriptions, therapies
Longevity
Medicine 3.0 strategies
Heart Health & Risk
Protect your heart & vessels
Metabolism
Insulin, blood sugar, weight
Hormones
TRT, thyroid, menopause, andropause
Performance
VO2 max, muscle, sleep, gut
Playbooks
Step-by-step frameworks
About
Meet Dr. Ash
Your Physician
GER·O·SPAN
Our Clinical Framework
What People Say
124 patient reviews across 6 platforms
Pricing & Membership
Transparent membership pricing
FAQ
Common Questions
Get Started
The GLP-1 Strategy
Fishtown Medicine•7 min read

The GLP-1 Strategy

Ashvin Vijayakumar MD

Medically Reviewed

Ashvin Vijayakumar MD•Updated October 15, 2025
On This Page
  • Why GLP-1 Medications Are a Big Deal
  • What Is the Muscle Math?
  • What Is the Fishtown GLP-1 Strategy?
  • 1. Resistance Training Is Non-Negotiable
  • 2. The Protein Prescription
  • 3. The Side Effect Plan
  • 4. The Exit Strategy
  • Guidance from the Clinic
  • Actionable Steps in Philly
  • Common Questions
  • How long does it take to see results on Ozempic or Wegovy?
  • What is the difference between Ozempic and Wegovy?
  • Are Mounjaro and Zepbound better than Ozempic?
  • How do I prevent muscle loss on a GLP-1?
  • What are the most common side effects?
  • Will I have to stay on Ozempic forever?
  • What happens to my face on Ozempic?
  • Can I drink alcohol on a GLP-1?
  • What should I eat while on Ozempic or Wegovy?
  • How much does it cost without insurance?
  • Deep Questions
  • How do GLP-1 medications change appetite at the brain level?
  • What is the SELECT trial and why does it matter?
  • Can GLP-1 medications help with addiction?
  • What is microdosing GLP-1s?
  • How do GLP-1 medications affect blood pressure?
  • What is "GLP-1 plateau" and how do you handle it?
  • How do compounded versions compare to brand-name?
  • What is the role of GIP in tirzepatide?
  • Can these medications affect mood?
  • How does sleep apnea respond to GLP-1 weight loss?
  • What about pancreatitis risk?
  • How do GLP-1 medications affect the gallbladder?
  • Can pregnant women take GLP-1 medications?
  • Are GLP-1 medications safe for adolescents?
  • How do you taper off a GLP-1 safely?
  • What labs should I track on a GLP-1?
  • How does pregnancy after GLP-1 weight loss work?
  • Can GLP-1 medications help with non-alcoholic fatty liver disease?
  • What are the long-term unknowns with GLP-1 medications?
  • Scientific References

Get a preventive doctor that knows you.

Consult Dr. Ash
TL;DR30-second take

GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are powerful tools for weight loss and metabolic health. The hard part is not prescribing them. The hard part is protecting muscle, hitting protein targets, managing side effects, and planning the off-ramp. We build the full plan, not just the script.

Why GLP-1 Medications Are a Big Deal

If you live in Philadelphia, you know someone on Ozempic, Wegovy, Zepbound, or Mounjaro. These are GLP-1 receptor agonists, a class of medications that mimic a gut hormone called GLP-1. They are not "cheating." They correct deep signaling errors in the brain and gut that drive hunger and metabolic dysfunction.

But there is a problem.

Most prescribers treat GLP-1 medications like a light switch. Turn it on, lose weight. They write the script, pat you on the back, and send you home.

That is not where the story should end. Rapid weight loss without a strategy can lead to sarcopenia (muscle loss), metabolic slowdown, "Ozempic face," and a real loss of long-term vitality. We do this differently.

What Is the Muscle Math?

When you lose weight rapidly, 20% to 40% of that weight can come from muscle. That is a disaster for long-term health.

  • Muscle is the largest glucose-disposal site in your body. It burns sugar at rest.
  • Muscle protects bones from fractures.
  • Higher muscle mass correlates with longer life expectancy.

If you lose 20 pounds of fat but also 10 pounds of muscle, you have technically improved your weight, but you may have worsened your long-term metabolic health and physical resilience.

What Is the Fishtown GLP-1 Strategy?

We follow the principles of Medicine 3.0. We use medications as tools, not as crutches. Our protocol has four parts.

1. Resistance Training Is Non-Negotiable

We require patients on GLP-1 medications to commit to resistance training, ideally 2 to 3 days per week. You must signal your body to keep its muscle. We help design a Zone 2 cardio and strength plan, or we connect you with local Philly trainers who understand the strategy.

2. The Protein Prescription

Your appetite will vanish on a GLP-1 medication. That means your protein intake will crash unless you plan ahead. We track protein closely. We typically target 1 gram per pound of ideal body weight per day. If solid food becomes hard, we use whey isolate or essential amino acid powders. You cannot build a body without bricks.

3. The Side Effect Plan

Nausea, constipation, fatigue, reflux, gallbladder pain. These are not "the price of weight loss." They are usually signs of dose mismatch or fast titration. Because we are a Direct Primary Care practice, you can text us: "Hey Dr. Ash, feeling nauseous today." We adjust the same day, not at your next 3-month visit.

4. The Exit Strategy

Do you want to be on this medication forever? Maybe you do, and that is clinically valid. But most patients want an off-ramp.

We plan the exit on day one. By building muscle and metabolic flexibility while you are on the medication, your body can defend its new set point. We taper the dose over months, not abruptly, and we keep tracking labs and body composition long after the script ends.

Guidance from the Clinic

"We are not just treating a number on a scale. We are treating your future physical independence. If you lose weight but lose the ability to lift a bag of groceries or carry a grandchild, we have failed. In Medicine 3.0, we build the chassis first, then we tune the engine."

A common question I hear: "Will I gain it all back when I stop?"

My honest answer: most patients regain about 30% to 50% of what was lost in the first year off, on average. That number drops a lot when patients have built muscle, fixed sleep, and have a maintenance plan in place. Many of my patients hold their loss with a low maintenance dose or with metformin and lifestyle alone.

Actionable Steps in Philly

Do not just lose weight. Audit your biology.

  1. Get a DEXA scan: A DEXA scan (a low-dose X-ray that measures fat, muscle, and bone) sets your lean mass baseline before you start. Without it, you cannot tell how much muscle you have lost.
  2. Audit your protein: Aim for 0.8 to 1 gram of protein per pound of ideal body weight. If solid food is hard on the medication, we prescribe high-quality amino acid or whey isolate support.
  3. Lift heavy things: Compound movements (squats, deadlifts, presses, rows) are your best defense against muscle loss. Two to three sessions per week, focusing on full-body work.

Metabolic Health

Insulin resistance often hides on standard labs. Find out where you really stand.

Schedule My Metabolic Review

Scientific References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. The STEP 1 trial.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
  3. Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes. N Engl J Med. 2023;389(24):2221-2232. The SELECT trial.
  4. Heymsfield SB, et al. Effect of Once-Weekly Semaglutide on Lean Body Mass. Diabetes Obes Metab. 2024.
  5. Malhotra A, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024. The SURMOUNT-OSA trial.
Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right GLP-1 plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, particularly if you have chronic health conditions or are taking prescription medications.
Ashvin Vijayakumar MD (Dr. Ash)

Fishtown Medicine | Metabolism

2418 E York St, Philadelphia, PA 19125·(267) 360-7927·hello@fishtownmedicine.com·HSA/FSA Eligible

Frequently Asked Questions

Common Questions

Most patients see appetite changes within the first week of GLP-1 therapy. Visible body changes usually start around 4 to 8 weeks once you reach a therapeutic dose. The biggest weight changes typically happen between months 2 and 6. Lab markers like fasting insulin and A1c (a 3-month blood sugar average) usually improve within 3 to 6 months.
Ozempic and Wegovy contain the same medication, semaglutide. Ozempic is FDA-approved for type 2 diabetes; Wegovy is FDA-approved for weight management. The dosing schedule for Wegovy goes higher (up to 2.4 mg weekly) than for Ozempic (up to 2.0 mg weekly). Insurance coverage differs based on the indication.
Mounjaro and Zepbound contain tirzepatide, which targets two receptors (GLP-1 and GIP) instead of one. In head-to-head trials, tirzepatide produced more weight loss than semaglutide, around 20% versus 14% over 72 weeks. Side effect profiles are similar. The right choice depends on response, insurance coverage, and your tolerance.
To prevent muscle loss on a GLP-1 medication, prioritize three things: protein intake of about 1 gram per pound of ideal body weight, resistance training 2 to 3 times per week with compound lifts, and creatine monohydrate (5 grams daily). Tracking grip strength and getting a DEXA scan every 6 months catches problems early.
The most common side effects of GLP-1 medications are nausea, constipation, reflux, fatigue, and decreased appetite. Most ease within 2 to 4 weeks of each dose increase. Less common but serious risks include pancreatitis, gallbladder problems, and severe dehydration. Rare risks include thyroid C-cell tumors, mostly seen in animal studies.
You do not necessarily have to stay on Ozempic forever. Some patients use it as a long-term tool, similar to blood pressure medications. Others taper off after building durable habits and muscle. About 30% to 50% of weight is regained within a year of stopping if no plan is in place. We design the exit from day one.
"Ozempic face" describes the gaunt, hollow look that some people get during rapid weight loss. Facial fat is lost along with body fat, and skin can take time to adjust. Slower weight loss, adequate protein, hydration, and resistance training help. Some patients use cosmetic options like fillers or PRP after weight stabilizes.
You can drink alcohol on a GLP-1, but most patients tolerate less than they used to. The slowed stomach emptying intensifies alcohols effects. Some patients lose interest in alcohol entirely, which research suggests may be a real effect of the medication on reward pathways. Going slow is wise, particularly in the first weeks.
While on Ozempic or Wegovy, eat protein-forward meals first (fish, eggs, chicken, tofu, Greek yogurt), add fiber from vegetables and fruit, and limit fried or very fatty foods that worsen nausea. Hydrate well. Smaller, more frequent meals are usually easier than 3 large ones. Avoid carbonated drinks during the early weeks.
Without insurance, brand-name GLP-1 medications cost about $1000 to $1300 per month. Compounded versions from licensed compounding pharmacies have been available for less, though the FDA has tightened compounding rules as supply has improved. Some manufacturers offer savings cards for commercial insurance patients.

Deep-Dive Questions

GLP-1 medications act on receptors in the hypothalamus (the brains hunger control center) and the brainstem. They reduce "food noise," the constant intrusive thoughts about eating that many patients with chronic obesity experience. They also slow stomach emptying, so meals stay satisfying longer. The combined effect is a major change in eating behavior.
The SELECT trial, published in 2023, showed that semaglutide reduced major cardiovascular events by 20% in non-diabetic patients with prior heart disease. This proved that GLP-1 medications protect the heart even when given specifically for weight, not blood sugar. It changed how cardiologists think about obesity treatment.
Some early studies suggest GLP-1 medications may reduce cravings for alcohol, nicotine, and other addictive substances. The mechanism likely involves the brains reward system, where GLP-1 receptors modulate dopamine signaling. Trials are underway specifically for alcohol use disorder. We do not prescribe these drugs for addiction yet, but we see this effect in many patients.
Microdosing GLP-1 medications means using doses below the FDA-approved range. Some clinicians use it for metabolic health and possible longevity benefits in patients who do not need significant weight loss. Long-term safety and benefit data are still emerging. We use it selectively in patients with mild metabolic dysfunction who tolerate full doses poorly.
GLP-1 medications lower blood pressure modestly, typically 3 to 5 mmHg systolic. Mechanisms include weight loss, improved kidney sodium handling, and direct vascular effects. Patients on blood pressure medications often need lower doses after starting GLP-1 therapy, so we watch for low blood pressure during titration.
GLP-1 plateau is when weight loss stalls after several months on the medication. Causes include receptor desensitization, behavior drift (snacking through the appetite suppression), and metabolic adaptation. We sometimes increase the dose, switch from semaglutide to tirzepatide, add metformin, or accept the new set point and move focus to body composition.
Compounded semaglutide and tirzepatide became available because of FDA-recognized drug shortages. Quality varies widely by pharmacy. We use compounded options only from licensed 503A or 503B pharmacies with strong quality controls. As brand-name supply has improved, the FDA has limited compounding eligibility, particularly for tirzepatide.
GIP (glucose-dependent insulinotropic polypeptide) is a second gut hormone that tirzepatide targets alongside GLP-1. GIP boosts insulin release after meals and may also influence fat metabolism and appetite. The dual action appears to produce more weight loss and possibly better metabolic effects than GLP-1 alone.
GLP-1 medications can affect mood in both directions. Most patients report feeling better, often because of weight loss, improved sleep, and better metabolic health. A small group reports low mood, anxiety, or anhedonia (reduced pleasure). The mechanism may involve changes in brain reward signaling. We screen for mood changes during follow-up.
Sleep apnea (a condition where breathing pauses during sleep) often improves substantially with GLP-1-driven weight loss. The SURMOUNT-OSA trial showed major reductions in sleep apnea severity with tirzepatide. Some patients can reduce or stop CPAP after sustained weight loss. We coordinate with sleep medicine specialists to monitor.
Pancreatitis (inflammation of the pancreas) is a rare but serious risk with GLP-1 medications. Population studies suggest the absolute risk is low, possibly slightly elevated above baseline. Patients with prior pancreatitis or gallstones are at higher risk. Severe abdominal pain that radiates to the back warrants immediate evaluation.
GLP-1 medications increase gallstone and gallbladder disease risk, partly because rapid weight loss itself raises that risk. Slower titration, adequate fat in the diet, and avoiding very low-fat eating may help. Severe right upper belly pain after meals warrants evaluation for gallstones.
Pregnant women should not take GLP-1 medications. Animal studies show possible developmental risks, and human data is limited. Women should stop the medication at least 2 months before trying to conceive, since the drug stays in the system for weeks. We coordinate with OB/GYN for women planning pregnancy.
Wegovy is FDA-approved for adolescents 12 and older with obesity. Use in this group requires careful evaluation, including mental health screening, family involvement, and growth monitoring. Long-term effects on growing bodies are still being studied. We coordinate care with pediatricians when this is the right path.
To taper off a GLP-1 safely, we usually drop one dose level every 1 to 2 months while watching for hunger return, weight changes, and lab drift. Staying on metformin (if useful), maintaining resistance training and protein intake, and protecting sleep all help hold the gains. Sudden stopping often leads to faster regain.
On a GLP-1 medication, we track A1c, fasting insulin, HOMA-IR, full thyroid panel, ApoB and lipid panel, kidney function, liver enzymes, electrolytes, and a yearly DEXA scan for body composition. We also check vitamin D, B12, and iron because food intake drops and absorption can change.
Pregnancy after GLP-1 weight loss is usually safer than pregnancy with high BMI, because risks like gestational diabetes, preeclampsia, and cesarean drop with lower weight. We recommend stopping the medication at least 2 months before trying to conceive. Many patients see fertility improve after weight loss, particularly those with PCOS.
GLP-1 medications can help with non-alcoholic fatty liver disease (now called metabolic dysfunction-associated steatotic liver disease or MASLD). Studies show they reduce liver fat substantially, often 30% to 50% over a year. The mechanism includes weight loss, lower insulin resistance, and possible direct liver effects. We monitor liver enzymes during treatment.
Long-term unknowns with GLP-1 medications include effects after 10 to 20 years of continuous use, effects on bone density beyond expected weight loss changes, possible effects on muscle quality at the cellular level, and rare downstream effects on the gut and pancreas. The base of safety data is strong from diabetes use, but obesity-focused long-term data is still building.

Ready when you are

Start your intake

Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.

Related Intelligence

Body Composition Optimization Philadelphia | HAES Medicine 3.0

Body Composition Optimization Philadelphia | HAES Medicine 3.0

Move beyond the scale. We focus on muscle mass and metabolic health using DEXA scans, in a HAES-aligned, Medicine 3.0 practice in Philadelphia.

Read Deep Dive
Precision Nutrition Philadelphia | Medicine 3.0 Protein Leverage

Precision Nutrition Philadelphia | Medicine 3.0 Protein Leverage

Stop chasing weight loss. Optimize for muscle mass and metabolic flexibility with Medicine 3.0 nutrition. Led by Ashvin Vijayakumar MD.

Read Deep Dive
Healthspan vs Lifespan: Why Living Longer Is Not Enough | Philadelphia

Healthspan vs Lifespan: Why Living Longer Is Not Enough | Philadelphia

Americans live to about 78 but spend the last 12 years sick and dependent. A Philadelphia primary care practice on why healthspan is the real metric.

Read Deep Dive

New patients

Talk it through with Dr. Ash.

If anything you read here raised a question, start with a short intake - your story in your own words. Dr. Ash reads every one personally, and you can text or email us anytime.

HSA/FSA eligible
No initiation or cancellation fees
No copays
Start your intake →
FishtownFish wrapped around the rod of AsclepiusMedicine
Philadelphia Primary Care
2418 E York St, Philadelphia, PA 19125Primary care in PhiladelphiaHome visits in Greater PhiladelphiaPricing & MembershipGER·O·SPAN: our clinical frameworkDigital Health Literacy

Serving Fishtown · Northern Liberties · East Kensington · Olde Richmond · Port Richmond · Old City · Callowhill · Poplar · Center City · Center City West · Art Museum · Bella Vista · Chestnut Hill · Fairmount · Fitler Square · Graduate Hospital · Logan Square · Manayunk · Queen Village · Rittenhouse · Roxborough · Society Hill · Southwark · Bryn Mawr, PA · Gladwyne, PA · Villanova, PA · Wayne, PA · Cherry Hill, NJ · Haddonfield, NJ · Medford, NJ · Moorestown, NJ · Voorhees, NJ

Explore by topic

Women’s Health
  • Perimenopause
  • Menopause 3.0
  • PCOS
  • Fertility
Men’s Health
  • Testosterone (TRT)
  • Sleep Apnea & Low T
  • Andropause
  • Low Libido
Metabolic
  • Medical Weight Loss
  • Ozempic vs Metformin
  • Fasting Protocols
  • Visceral Fat
Cardiovascular
  • apoB & Heart Health
  • apoB vs LDL
  • Lp(a) Cholesterol
  • ED & Heart Risk
Longevity + Performance
  • Healthspan vs Lifespan
  • Biological Age
  • VO2 Max
  • Zone 2 Training
Supplements
  • Magnesium
  • Creatine
  • Omega-3
  • Foundational Stack
  • Supplement Guides
Care in Philadelphia +
Direct Primary Care in Philadelphia, PAConcierge Medicine in Philadelphia, PAConcierge vs DPC in Philadelphia, PALongevity Medicine in Philadelphia, PAPreventive Care in Philadelphia, PAExecutive Physical in Philadelphia, PAAnnual Physical in Philadelphia, PAHealthspan Optimization in Philadelphia, PAFunctional Medicine in Philadelphia, PASame-Day Sick Visits in Philadelphia, PATestosterone Replacement Therapy in Philadelphia, PAPerimenopause Care in Philadelphia, PAMenopause Care in Philadelphia, PAThyroid Treatment in Philadelphia, PAPCOS Care in Philadelphia, PAGLP-1 Weight Loss in Philadelphia, PAMetabolic Health in Philadelphia, PAHormone Optimization in Philadelphia, PAAdvanced Lipid Testing in Philadelphia, PAVO2 Max Testing in Philadelphia, PADEXA Scan in Philadelphia, PACGM in Philadelphia, PALong COVID Care in Philadelphia, PAChronic Fatigue Treatment in Philadelphia, PAPOTS Treatment in Philadelphia, PAMCAS Treatment in Philadelphia, PALyme Disease Care in Philadelphia, PABrain Fog Treatment in Philadelphia, PASleep Disorders Treatment in Philadelphia, PAStrep Throat Treatment in Philadelphia, PAUTI Treatment in Philadelphia, PASinus Infection Treatment in Philadelphia, PASTI Testing in Philadelphia, PATravel Medicine in Philadelphia, PAPre-Op Clearance in Philadelphia, PASports Club Medicine in Philadelphia, PA

Made it this far? You’re already most of the way there. let’s get started → Dr. Ash reads every word personally.

Content is for educational purposes only and does not constitute medical advice.

TermsPrivacyScope of PracticeClinical Independence